Delivery Order SPE2DR25D1109-SPE2DR26FFG1M
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,217.40 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents on October 27, 2025. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of October 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,383.60 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 28, 2025. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and critical vendor for federal medical procurement....
- The Defense Logistics Agency awarded a $10,479 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of September 24, 2025. This competitively awarded, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Rabavert rabies vaccine with diluents. This $6,287.40 firm fixed-price delivery order is a non-set-aside contract with an ultimate completion date of September 30, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed-price contract valued at $18,728.13. The order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued...
- The Defense Logistics Agency awarded a $41,916 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger contract vehicle supporting federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,297.80 firm fixed price delivery order for Rabavert rabies vaccine with diluents, effective August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,122.93 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a completion date of September 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a...
- The Defense Logistics Agency awarded a $1,047.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents on September 16, 2025, with an ultimate completion date of September 17, 2025. The contract is unclassified with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed-price contract valued at $1,676.72. The award was made on October 29, 2025, with an ultimate completion date of October 30, 2025, and represents a non-set-aside competitive procurement. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFG1MDelivery Order
The Defense Logistics Agency awarded a $28,406 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents on November 6, 2025, with an ultimate completion date of November 7, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements through open competition, including vaccines, specialty medications, and branded and generic drugs across multiple therapeutic domains. This award reflects the company's ongoing role as a primary supplier supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.4k | 11/6/25 |